MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Hepatitis B virus (HBV) clearance depends on integrated innate and adaptive immune responses.
• MITA/STING is a key adapter protein in innate immunity, regulating responses to DNA viruses.
• An alternatively spliced isoform, MITA-related protein (MRP), selectively inhibits MITA-mediated interferon induction while activating NF-κB.

Purpose of the Study:

• To investigate the roles of MITA/STING and MRP in controlling HBV replication.
• To elucidate the distinct mechanisms by which MITA/STING and MRP influence HBV infection.
• To assess the impact of MITA/STING on adaptive immune responses during HBV infection.

Main Methods:

• In vitro assays to assess HBV replication inhibition by MITA/STING and MRP.
• Overexpression studies to analyze the activation of IRF3-IFN and NF-κB pathways.
• Hydrodynamic injection mouse model to evaluate the in vivo effects of MITA/STING and MRP.
• Analysis of HBV-specific humoral and CD8+ T cell responses in MITA/STING-deficient mice.

Main Results:

• Both MITA/STING and MRP significantly inhibited HBV replication in vitro.
• MITA/STING activated the IRF3-IFN pathway, while MRP activated the NF-κB pathway.
• Expression of MITA/STING and MRP vectors reduced HBV replication in mice.
• HBV replication was enhanced in MITA/STING-knockout mice.
• Mice deficient in MITA/STING exhibited impaired HBV-specific humoral and CD8+ T cell responses.

Conclusions:

• MITA/STING and MRP are critical regulators of innate and adaptive immunity against HBV.
• These proteins inhibit HBV replication through distinct signaling pathways.
• MITA/STING plays a vital role in initiating adaptive immune responses essential for controlling HBV infection.